- Home
- JKS vs XERS Comparison
JKS vs XERS Comparison
Compare JKS & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JKS
- XERS
- Stock Information
- Founded
- JKS 2006
- XERS 2005
- Country
- JKS China
- XERS United States
- Employees
- JKS N/A
- XERS N/A
- Industry
- JKS Semiconductors
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- JKS Technology
- XERS Health Care
- Exchange
- JKS Nasdaq
- XERS Nasdaq
- Market Cap
- JKS 1.2B
- XERS 1.3B
- IPO Year
- JKS 2010
- XERS 2018
- Fundamental
- Price
- JKS $24.15
- XERS $8.24
- Analyst Decision
- JKS Sell
- XERS Strong Buy
- Analyst Count
- JKS 4
- XERS 7
- Target Price
- JKS $28.99
- XERS $8.00
- AVG Volume (30 Days)
- JKS 581.3K
- XERS 2.1M
- Earning Date
- JKS 10-29-2025
- XERS 11-07-2025
- Dividend Yield
- JKS 6.21%
- XERS N/A
- EPS Growth
- JKS N/A
- XERS N/A
- EPS
- JKS N/A
- XERS N/A
- Revenue
- JKS $11,445,691,729.00
- XERS $246,025,000.00
- Revenue This Year
- JKS N/A
- XERS $43.89
- Revenue Next Year
- JKS $31.21
- XERS $20.40
- P/E Ratio
- JKS N/A
- XERS N/A
- Revenue Growth
- JKS N/A
- XERS 35.62
- 52 Week Low
- JKS $13.42
- XERS $2.73
- 52 Week High
- JKS $29.80
- XERS $8.51
- Technical
- Relative Strength Index (RSI)
- JKS 49.12
- XERS 56.10
- Support Level
- JKS $23.92
- XERS $7.95
- Resistance Level
- JKS $25.93
- XERS $8.39
- Average True Range (ATR)
- JKS 0.96
- XERS 0.33
- MACD
- JKS -0.15
- XERS -0.02
- Stochastic Oscillator
- JKS 35.34
- XERS 57.29
About JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).